Related Articles
Telmisartan is a potent target for prevention and treatment in human prostate cancer
Telmisartan inhibits human urological cancer cell growth through early apoptosis
Telmisartan as a peroxisome proliferator-activated receptor-γ ligand is a new target in the treatment of human renal cell carcinoma
Angiotensin II type-1 receptor blockers enhance the effects of bevacizumab-based chemotherapy in metastatic colorectal cancer patients
CD147 modulates autophagy through the PI3K/Akt/mTOR pathway in human prostate cancer PC-3 cells